Your browser is no longer supported. Please, upgrade your browser.
ARK Genomic Revolution ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-3.86%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-5.50%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-23.24%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y17.46%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year124.44%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range36.62 - 115.15 Perf YTD-7.92%
Dividend0.79 P/FCF- EPS past 5Y- ROI- 52W High-26.28% Beta-
Dividend %0.92% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low131.79% ATR3.17
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)40.32 Volatility3.13% 3.47%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.35 Prev Close85.87
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.12M Price84.89
Recom- SMA20-3.09% SMA50-9.21% SMA2006.92% Volume94,619 Change-1.14%
Mar-30-21 04:45PM  
Mar-25-21 11:00AM  
Mar-17-21 08:01AM  
Mar-16-21 10:30AM  
Mar-08-21 10:00AM  
Feb-19-21 09:50AM  
Feb-10-21 03:19PM  
Feb-03-21 01:47PM  
Feb-01-21 12:00AM  
Jan-29-21 09:45AM  
Jan-23-21 11:30PM  
Jan-21-21 02:43PM  
Jan-08-21 05:36PM  
Dec-31-20 06:30AM  
Dec-16-20 12:16PM  
Nov-09-20 03:15PM  
Sep-18-20 12:00AM  
Jun-23-20 11:10AM  
Apr-06-20 04:30PM  
Feb-18-20 11:12AM  
Feb-05-20 10:56AM  
Jan-23-20 04:29PM  
Jan-22-20 09:00AM  
Jan-06-20 11:14AM  
Dec-23-19 11:18AM  
Dec-20-19 09:30AM  
Dec-19-19 04:48PM  
Dec-12-19 05:33PM  
Dec-10-19 04:16PM  
Dec-02-19 02:40PM  
Nov-29-19 12:15PM  
Nov-27-19 05:33PM  
Nov-25-19 06:55PM  
Nov-18-19 05:49PM  
Nov-14-19 04:06PM  
Nov-13-19 05:37PM  
Nov-04-19 10:10AM  
Oct-30-19 03:14PM  
Oct-23-19 04:24PM  
Oct-16-19 01:00PM  
Oct-01-19 04:23PM  
Sep-30-19 06:17PM  
Sep-24-19 08:00AM  
Sep-19-19 12:51PM  
Sep-06-19 03:07PM  
Sep-04-19 03:18PM  
Sep-03-19 05:46PM  
Jul-03-19 10:50AM  
Jun-28-19 11:15AM  
Jun-24-19 04:23PM  
Jun-21-19 05:31PM  
Jun-18-19 09:55AM  
May-14-19 10:22AM  
May-09-19 07:46AM  
May-06-19 06:05PM  
May-02-19 02:30PM  
Apr-12-19 01:00PM  
Apr-11-19 03:33PM  
Apr-10-19 04:44PM  
Apr-05-19 01:18PM  
Apr-02-19 03:34PM  
Apr-01-19 11:30AM  
Mar-28-19 11:58AM  
Mar-27-19 10:15AM  
Mar-18-19 08:00AM  
Mar-01-19 03:20PM  
Feb-28-19 10:15AM  
Feb-27-19 03:00PM  
Feb-26-19 11:15AM  
Feb-04-19 11:16AM  
Jan-14-19 10:09AM  
Dec-04-18 03:27PM  
Dec-03-18 05:01PM  
Nov-19-18 11:50AM  
Nov-12-18 11:51AM  
Oct-24-18 02:44PM  
Oct-01-18 12:59PM  
Sep-25-18 03:19PM  
Sep-12-18 09:24AM  
Sep-04-18 01:45PM  
Aug-31-18 12:38PM  
Aug-24-18 06:00AM  
Aug-22-18 03:22PM  
Aug-20-18 09:24AM  
Jul-31-18 03:52PM  
Jul-27-18 08:17AM  
Jul-16-18 11:39AM  
Jul-12-18 11:24AM  
Jul-11-18 03:54PM  
The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.